European Companies Search Engine
EU funding (€3,924,325): Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia Hor23 Sept 2016 EU Research and Innovation programme "Horizon"
Overview
Text
Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia
The research in which the young scientists of the EU-GliaPhD consortium will be trained is centred on the role of neuron-glia interactions in brain function and pathology. Prompted by exciting discoveries of recent years, many academic research groups are currently focussing their research on the field of neuron-glia interactions for a better understanding of brain function. Also the private sector such as the pharmaceutical industry pays more and more attention to the role of neuroglia in various neuropathologies. These research activities create an increasing demand for outstanding young neuroscientists to join academia or industry. To address this need for neuroscientists with a strong knowledge in neuron-glia interactions, the EU-GliaPhD consortium of recognized European neuroscientists decided to initiate a training network in which young scientists, the EU-GliaPhD fellows will be educated in collaborative research projects to study neuron-glia interactions at the molecular, cellular and systems level in the healthy and the diseased brain. A strong emphasis will lie on epilepsy, a multi-faceted, chronic neurological disorder characterized by the frequent recurrence of seizures. The EU-GliaPhD consortium will focus on five important educational and training objectives: 1. Broad training in several current state-of-art technologies that are highly relevant for brain research 2. Teaching an in-depth understanding of molecular and cellular neurobiology and -pathology 3. Focused specialization in defined research projects 4. Training in dissemination of modern neuroscience research to expert and lay audiences 5. Education in soft skills such as article writing, oral presentations or research ethics By studying epilepsy, fundamental questions on the cellular and molecular aspects of neuron-glia interaction can be addressed. Novel insight delivered by EU-GliaPhD may serve as basis for the development of novel strategies in treating brain disorders.
Funded Companies:
| Company name | Funding amount |
| CARL ZEISS MICROSCOPY GmbH | ? |
| ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM | €0.00 |
| AMSTERDAM UMC RESEARCH B.V. | €255,374 |
| Aston University | €273,288 |
| Cardiff University | €273,288 |
| College de France | €262,876 |
| Consiglio Nazionale Delle Ricerche | €516,123 |
| Fondazione Irccs Istituto Neurologico Carlo Besta | €258,061 |
| H. Lundbeck AS | €290,082 |
| Institut National de la Sante et de la Recherche Medicale | €262,876 |
| NPI ELECTRONIC GESELLSCHAFT FUR ELEKTRONISCHE MESS- UND REGELSYSTEME mbH | €249,216 |
| Oslo Universitetssykehus HF | €286,275 |
| UNIVERSITAT DES SAARLANDES | €498,433 |
| UNIVERSITATSKLINIKUM BONN | €498,433 |
Source: https://cordis.europa.eu/project/id/722053
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Carl Zeiss Microscopy GmbH, Jena, Germany.
The visualizations for "CARL ZEISS MICROSCOPY GmbH - EU funding (€3,924,325): Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
